Head to Head Review: Auna (NYSE:AUNA) & SHL Telemedicine (NASDAQ:SHLT)

Auna (NYSE:AUNA) and SHL Telemedicine (NASDAQ:SHLT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings.

Institutional and Insider Ownership

20.1% of SHL Telemedicine shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Auna and SHL Telemedicine”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Auna	$4.39 billion	0.12	-$67.90 million	$0.38	18.42
SHL Telemedicine	$55.94 million	0.60	-$7.06 million	N/A	N/A

SHL Telemedicine has lower revenue, but higher earnings than Auna.

Profitability

This table compares Auna and SHL Telemedicine’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Auna	N/A	N/A	N/A
SHL Telemedicine	N/A	N/A	N/A

Risk and Volatility

Auna has a beta of 3.2, meaning that its stock price is 220% more volatile than the S&P 500. Comparatively, SHL Telemedicine has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Auna and SHL Telemedicine, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Auna	0	0	1	0	3.00
SHL Telemedicine	0	0	0	0	0.00

Auna presently has a consensus target price of $13.50, suggesting a potential upside of 92.86%. Given Auna’s stronger consensus rating and higher probable upside, equities analysts clearly believe Auna is more favorable than SHL Telemedicine.

Summary

Auna beats SHL Telemedicine on 5 of the 8 factors compared between the two stocks.

About Auna

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices, including blood pressure, weighing, oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather), and sugar measuring devices; and TelePress, a remote blood pressure monitoring device for personal use. It offers its telemedicine services and devices to subscribers using electronic and telecommunication technologies. The company serves physicians, hospitals, health insurance funds, and patients. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was incorporated in 1986 and is headquartered in Tel Aviv, Israel.